ECONAZOLE NITRATE

Post-LOE

econazole nitrate

Aurobindo Pharma

ANDATOPICALCREAM

Approved

Apr 2018

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

4/8 — Partial

ECONAZOLE NITRATE (econazole nitrate) by Aurobindo Pharma is - 12. Approved for interdigital tinea pedis caused by trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum in patients 12 years of age and 1 more indications. First approved in 2018.

Drug data last refreshed 18h ago

$0.0BPart D

Mechanism of Action

- 12.1 Mechanism of Action Econazole nitrate topical foam is an azole antifungal [ see ] . 12.2 Pharmacodynamics The pharmacodynamics of econazole nitrate topical foam, 1% have not been established . 12.3 Pharmacokinetics The systemic absorption of econazole nitrate topical foam, 1% following…

Worked on ECONAZOLE NITRATE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

ECONAZOLE NITRATE

Mechanism of Action

Indications (4)